These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8818240)

  • 1. 2-Amino diphenylsulfides as inhibitors of trypanothione reductase: modification of the side chain.
    Baillet S; Buisine E; Horvath D; Maes L; Bonnet B; Sergheraert C
    Bioorg Med Chem; 1996 Jun; 4(6):891-9. PubMed ID: 8818240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent and specific inhibitors of trypanothione reductase from Trypanosoma cruzi: bis(2-aminodiphenylsulfides) for fluorescent labeling studies.
    Girault S; Davioud-Charvet TE; Maes L; Dubremetz JF; Debreu MA; Landry V; Sergheraert C
    Bioorg Med Chem; 2001 Apr; 9(4):837-46. PubMed ID: 11354666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
    Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
    J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity.
    Salmon-Chemin L; Buisine E; Yardley V; Kohler S; Debreu MA; Landry V; Sergheraert C; Croft SL; Krauth-Siegel RL; Davioud-Charvet E
    J Med Chem; 2001 Feb; 44(4):548-65. PubMed ID: 11170645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of potential trypanothione reductase inhibitors among commercially available β-carboline derivatives using chemical space, lead-like and drug-like filters, pharmacophore models and molecular docking.
    Rodríguez-Becerra J; Cáceres-Jensen L; Hernández-Ramos J; Barrientos L
    Mol Divers; 2017 Aug; 21(3):697-711. PubMed ID: 28656524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships in 2-aminodiphenylsulfides against trypanothione reductase from Trypanosoma cruzi.
    Girault S; Davioud-Charvet E; Salmon L; Berecibar A; Debreu MA; Sergheraert C
    Bioorg Med Chem Lett; 1998 May; 8(10):1175-80. PubMed ID: 9871730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase/trypanothione reductase inhibitors against Trypanosoma brucei and Trypanosoma cruzi.
    Belluti F; Uliassi E; Veronesi G; Bergamini C; Kaiser M; Brun R; Viola A; Fato R; Michels PA; Krauth-Siegel RL; Cavalli A; Bolognesi ML
    ChemMedChem; 2014 Feb; 9(2):371-82. PubMed ID: 24403089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activity.
    Uliassi E; Fiorani G; Krauth-Siegel RL; Bergamini C; Fato R; Bianchini G; Carlos Menéndez J; Molina MT; López-Montero E; Falchi F; Cavalli A; Gul S; Kuzikov M; Ellinger B; Witt G; Moraes CB; Freitas-Junior LH; Borsari C; Costi MP; Bolognesi ML
    Eur J Med Chem; 2017 Dec; 141():138-148. PubMed ID: 29031061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of 9,9-dimethylxanthene tricyclics against trypanothione reductase, Trypanosoma brucei, Trypanosoma cruzi and Leishmania donovani.
    Chibale K; Visser M; Yardley V; Croft SL; Fairlamb AH
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1147-50. PubMed ID: 10866368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dibenzosuberyl substituted polyamines and analogs of clomipramine as effective inhibitors of trypanothione reductase; molecular docking, and assessment of trypanocidal activities.
    O'Sullivan MC; Durham TB; Valdes HE; Dauer KL; Karney NJ; Forrestel AC; Bacchi CJ; Baker JF
    Bioorg Med Chem; 2015 Mar; 23(5):996-1010. PubMed ID: 25661449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypanothione Reductase: A Target for the Development of Anti- Trypanosoma cruzi Drugs.
    Vázquez K; Paulino M; Salas CO; Zarate-Ramos JJ; Vera B; Rivera G
    Mini Rev Med Chem; 2017; 17(11):939-946. PubMed ID: 28302040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arylfurans as potential trypanosoma cruzi trypanothione reductase inhibitors.
    de Oliveira RB; Vaz AB; Alves RO; Liarte DB; Donnici CL; Romanha AJ; Zani CL
    Mem Inst Oswaldo Cruz; 2006 Mar; 101(2):169-73. PubMed ID: 16830710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyamines with N-(3-phenylpropyl) substituents are effective competitive inhibitors of trypanothione reductase and trypanocidal agents.
    Li Z; Fennie MW; Ganem B; Hancock MT; Kobaslija M; Rattendi D; Bacchi CJ; O'Sullivan MC
    Bioorg Med Chem Lett; 2001 Jan; 11(2):251-4. PubMed ID: 11206471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypanothione reductase inhibition/trypanocidal activity relationships in a 1,4-bis(3-aminopropyl)piperazine series.
    Bonnet B; Soullez D; Girault S; Maes L; Landry V; Davioud-Charvet E; Sergheraert C
    Bioorg Med Chem; 2000 Jan; 8(1):95-103. PubMed ID: 10968268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitrypanosomal, antileishmanial, and antimalarial activities of quaternary arylalkylammonium 2-amino-4-chlorophenyl phenyl sulfides, a new class of trypanothione reductase inhibitor, and of N-acyl derivatives of 2-amino-4-chlorophenyl phenyl sulfide.
    Parveen S; Khan MO; Austin SE; Croft SL; Yardley V; Rock P; Douglas KT
    J Med Chem; 2005 Dec; 48(25):8087-97. PubMed ID: 16335933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and 2D-QSAR studies of neolignan-based diaryl-tetrahydrofuran and -furan analogues with remarkable activity against Trypanosoma cruzi and assessment of the trypanothione reductase activity.
    Hartmann AP; de Carvalho MR; Bernardes LSC; Moraes MH; de Melo EB; Lopes CD; Steindel M; da Silva JS; Carvalho I
    Eur J Med Chem; 2017 Nov; 140():187-199. PubMed ID: 28926763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural analysis and molecular docking of trypanocidal aryloxy-quinones in trypanothione and glutathione reductases: a comparison with biochemical data.
    Vera B; Vázquez K; Mascayano C; Tapia RA; Espinosa V; Soto-Delgado J; Salas CO; Paulino M
    J Biomol Struct Dyn; 2017 Jun; 35(8):1785-1803. PubMed ID: 27232454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design of nitrofuran derivatives: Synthesis and valuation as inhibitors of Trypanosoma cruzi trypanothione reductase.
    Arias DG; Herrera FE; Garay AS; Rodrigues D; Forastieri PS; Luna LE; Bürgi MD; Prieto C; Iglesias AA; Cravero RM; Guerrero SA
    Eur J Med Chem; 2017 Jan; 125():1088-1097. PubMed ID: 27810595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanocidal bisbenzylisoquinoline alkaloids are inhibitors of trypanothione reductase.
    Fournet A; Inchausti A; Yaluff G; Rojas De Arias A; Guinaudeau H; Bruneton J; Breidenbach MA; Karplus PA; Faerman CH
    J Enzyme Inhib; 1998 Feb; 13(1):1-9. PubMed ID: 9879510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological Evaluation and X-ray Co-crystal Structures of Cyclohexylpyrrolidine Ligands for Trypanothione Reductase, an Enzyme from the Redox Metabolism of Trypanosoma.
    De Gasparo R; Brodbeck-Persch E; Bryson S; Hentzen NB; Kaiser M; Pai EF; Krauth-Siegel RL; Diederich F
    ChemMedChem; 2018 May; 13(9):957-967. PubMed ID: 29624890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.